
An image of the proteoglycans that have increased in the perineuronal net (green) that surrounds nerve cells (red) in the spinal cord following injury. Proteoglycans in the net limit functional regeneration and plasticity after spinal cord injury. The chondroitinase enzyme removes the net and allows for regeneration and functional recovery, especially at chronic stages.
Promising results provide hope for humans suffering from chronic paralysis
Millions of people worldwide are living with chronic spinal cord injuries, with 250,000 to 500,000 new cases each year—most from vehicle crashes or falls. The most severe spinal cord injuries completely paralyze their victims and more than half impair a person’s ability to breathe. Now, a breakthrough study published in Nature Communications has demonstrated, in animal models of chronic injury, that long-term, devastating effects of spinal cord trauma on breathing and limb function may be reversible.
The new study describes a treatment regimen that helps reawaken certain special types of nerve cells that can regenerate extensions, called axons, within the damaged spinal cord. Rats with spinal cords half severed at the second cervical vertebrae (C2) regained complete diaphragm and partial forelimb function on the severed side after treatment. The recuperative effects of the therapy were fully maintained six months after treatment end.
“For the first time we have permanently restored both breathing and some arm function in a form of high cervical, chronic spinal cord injury-induced paralysis. The complete recovery, especially of breathing, occurs rapidly after a near lifetime of paralysis in a rodent model,” says senior author Jerry Silver, PhD, professor of neurosciences at Case Western Reserve University School of Medicine.
The treatment leverages the body’s innate ability to very slowly sprout new axon branches from a sub-population of nerve cells that remain intact below the injury. The activity of these new branches is completely stifled by a family of potently inhibitory molecules called proteoglycans. Said Silver, “The strategy was to use a simple, one-time injection of an enzyme, chondroitinase, that breaks down the inhibitory proteoglycan molecules. The enzyme was administered, not within the lesion itself, but lower down within the spinal cord where motor nerve cells reside that send axons out to the diaphragm and forearm.”
In animals treated immediately after spinal cord injury, the enzyme only marginally helped restore nerve growth with minimal functional recovery. However, in animals treated long after injury, the therapeutic effects of the enzyme were remarkably better. In as little as one week after treatment in chronically injured rats, new nerve extensions began to restore diaphragm function that had been silent for many months. Seventy percent of rats treated with the enzyme chronically, also began to use their forelimbs to move about and explore their environment (compared to only 30 percent of control animals).
“Surprisingly, the technique worked far better at chronic stages than at acute stages after injury,” says Silver. The longer the animals had been paralyzed, the greater were the restorative effects of the enzyme. Silver’s team found that even after an unprecedented year and a half following spinal cord injury, the treatment could recover full activity to rat diaphragms. One week after treatment, 60 percent of the animals had improved diaphragm function. Two weeks later, every rat showed improvement—even though their paralysis had lasted most of their lives.
Interestingly, exposing the rats to brief periods of low oxygen levels, a respiratory therapy known as acute intermittent hypoxia, helped strengthen the growing nerve extensions, providing an added benefit. However, Silver’s team found that when the rats were treated with the enzyme combined with excessive amounts of respiratory therapy, rats developed chaotic activity in their once paralyzed diaphragms. The researchers hypothesized that the potential for highly abnormal activity may be why the body releases inhibitory molecules to prevent functional axon regeneration in the spinal cord. They are now working to optimize the combination therapy to maximize recovery, especially in the forearm and paw.
“Our data illustrate the relative ease with which an essential motor system can regain functionality months to years after severe spinal cord injury,” says Silver. “The treatment regimen in our study is relevant to multiple types of chronic incomplete spinal traumas, and we are hopeful it may also help restore motor function following spinal cord injury in humans.”
The Latest on: Spinal cord injury
via Google News
The Latest on: Spinal cord injury
- Evaluating patient perspectives on participating in scientific research and clinical trials for the treatment of spinal cord injuryon February 23, 2021 at 5:33 am
A questionnaire was developed to evaluate patients’ perspective on research aimed at improving functions and overcoming complications associated with spinal cord injury (SCI). T ...
- Scientists use patients' own stem cells to restore function after spinal cord injuryon February 22, 2021 at 3:49 pm
Intravenous injection of bone marrow derived stem cells (MSCs) in patients with spinal cord injuries led to significant improvement in motor functions, researchers from Yale University and Japan ...
- Massachusetts HS hockey player speaks publicly for first time since serious spinal cord injuryon February 21, 2021 at 6:18 am
In a video shared on Twitter, A.J. Quetta thanked everyone for their support, especially his teammates at Bishop Feehan High School.
- Watch: Teen hockey player says he's thankful for support after spinal injuryon February 20, 2021 at 1:13 pm
Bishop Feehan hockey player A.J. Quetta, who suffered a serious spinal cord injury in January, released a video message thanking his teammates and everyone else who has supported him.
- InVivo is up after peer-reviewed publication of study on spinal cord injuryon February 16, 2021 at 2:17 pm
InVivo Therapeutics is trading higher today in above-average volumeafter the company announcedthe publication of a peer-reviewed manuscript describing ...
- Assessment of neuropathic pain after spinal cord injury using quantitative pain drawingson February 16, 2021 at 12:14 pm
Clinimetric cross-sectional cohort study in adults with paraplegic spinal cord injury (SCI) and neuropathic pain (NP). Objective. To assess the reliability of standa ...
- Injury firm goes countrywide with new office openingon February 16, 2021 at 2:59 am
A serious injury claims specialist that started life in the north west has continued its expansion across the country with a new team hire. CFG Law today announced it will open a new office in Bury St ...
- Electrical Stimulation for Improved Function Post-Spinal Cord Injury: Interview with Dave Marver, CEO, ONWARDon February 10, 2021 at 1:59 pm
You may have seen an article Medgadget published recently about a minimally invasive neuromodulation technology that has shown significant promise in ...
- Electrical Stimulation Stabilizes BP in Spinal Cord Injuryon February 3, 2021 at 3:52 pm
A new device that targets electrical stimulation to the spinal cord can stabilize blood pressure in people with spinal cord injury, possibly preventing the debilitating episodes of orthostatic ...
via Bing News